The immunomodulatory role of paracrine signalling factor VSIG4 in peritoneal metastases-Reference-Cited by-同舟云学术

The immunomodulatory role of paracrine signalling factor VSIG4 in peritoneal metastases

Published:2024-07-30 Issue:1 Volume:14 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Chong Yik Yan,Thiagarajan Sasinthiran,Tan Qiu Xuan,Lim Hui Jun,Tan Joey Wee-Shan,Hendrikson Josephine,Ng Gillian,Liu Ying,Chong Clara Yieh Lin,Guo Wanyu,Ngo Nye Thane,Leow Wei-Qiang,Loh Tracy,Sam Xin Xiu,Lim Tony Kiat Hon,Cai Mingzhe,Seo Chin Jin,Wong Jolene Si Min,Soo Khee Chee,Chia Claramae Shulyn,Shannon Nicholas Brian,Ong Chin-Ann Johnny

Funder

National Medical Research Council

Publisher

Springer Science and Business Media LLC

Link

https://www.nature.com/articles/s41598-024-64449-y.pdf

Reference16 articles.

1. Mármol, I., Sánchez-de-Diego, C., Pradilla Dieste, A., Cerrada, E. & Rodriguez Yoldi, M. J. Colorectal carcinoma: A general overview and future perspectives in colorectal cancer. Int. J. Mol. Sci. 18, 197 (2017).

2. Coccolini, F. Peritoneal carcinomatosis. World J. Gastroenterol. 19, 6979 (2013).

3. Franko, J. et al. Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: An analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database. Lancet Oncol 17, 1709–1719 (2016).

4. Glehen, O., Mohamed, F. & Gilly, F. N. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia. Lancet Oncol. 5, 219–228 (2004).

5. Bartlett, E. K. et al. Morbidity and mortality of cytoreduction with intraperitoneal chemotherapy: Outcomes from the ACS NSQIP database. Ann. Surg. Oncol. 21, 1494–1500 (2014).